Vaxart Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Welcome to the Cantor Global Healthcare Conference, I'm Pete Stavropoulos, biotech analyst with Cantor. With us, we have Vaxart and I'm pleased to introduce Andrei Floroiu, CEO; and James Cummings, CMO.
Vaxart is a company that we do cover the or vaccine focused company with a platform that's designed to stimulate mucosal immunity. So a very unique platform called VAAST. So with that, welcome I you.
Thanks.
Thank you so much. We're happy to be here. So I guess we'll show you a few slides and then Pete ask us questions. (multiple speakers) -- Yeah.
Forward-looking statements. All investors should go through this, not going to spend too much time on them. This is an executive summary, but I'll spend more time on it at the end, just go into into what we're here to talk about.
And what we're here to talk about is how can Vaxart
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
